B. Teicher

Oncology · 2010–2013

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom B. Teicher trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Shahin Rafii

Papers from B. Teicher's perspective

Ordered by how strongly the researchers B. Teicher trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (EMBO Molecular Medicine)
  2. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks (Cell)
  3. DNA damage, aging, and cancer. (New England Journal of Medicine)
  4. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. (Frontiers in Bioscience)
  5. Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
  6. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set (Cancer Research)
  7. The DNA damage response and cancer therapy (Nature)
  8. Structural basis for DNA-dependent poly(ADP-ribosyl)ation by human PARP-1 (Science)
  9. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. (Trends in immunology)
  10. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 (Nature Immunology)

Their papers